Case Studies
iAnthus Reports Q1 2026 Financial Results
NEW YORK-TORONTO – iAnthus Capital Holdings posted its fiscal first-quarter ...
Vlasic Labs CBD Products Qualify for CMS Medicare Pilot Program
BLOOMFIELD HILLS – Vlasic Labs announced that its cannabidiol product ...
Cannabist Closes $130M Sale of Virginia Assets
CHELMSFORD – The Cannabist Co. Holdings Inc. completed the sale of its Virginia Cannabis business to an affiliate of Millstreet Credit Fund LP, generating total consideration of $130 million. The deal involves the transfer of ...
Canopy Growth Reports Q3 Fiscal 2026 Financial Results
SMITHS FALLS, ON – Canopy Growth Corp. reported its financial results for the third quarter of fiscal 2026, ended December 31, 2025, showing progress in cost control and Canadian operations despite flat overall revenue. Consolidated ...
NY Cannabis Hits First $500M Quarter
NEW YORK – New York's legal Cannabis market set a new record by closing 2025 with its first quarter exceeding $500 million in sales, positioning the state for continued strong performance into 2026. The Office ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered a surge of momentum across the U.S. Cannabis and Psychedelics sectors, where federal signals on coverage and equity met bold state actions on access and licensing. Operators navigated ...
Psychedelics Advance in Federal Arena as Trials and Policies Align
LOS ANGELES – Federal health officials under the Trump administration have begun to signal stronger backing for psychedelic therapies, setting the stage for possible FDA approvals of MDMA and psilocybin treatments within the next 18 ...
RESPECT: House Lawmakers Introduce Cannabis Equity Resolution
WASHINGTON – A group of eight House lawmakers, led by members of the Congressional Cannabis Caucus, filed a resolution aimed at bolstering fair access to the burgeoning Cannabis sector for communities long sidelined by federal ...
Bipartisan Measure Targets Barriers to Psychedelic Therapies for Terminal Patients
WASHINGTON – A group of House and Senate lawmakers from both parties unveiled legislation to permit physicians to deliver Schedule I substances, including MDMA and psilocybin, to individuals grappling with terminal illnesses or severe mental ...
Cannabist Closes $130M Sale of Virginia Assets
CHELMSFORD – The Cannabist Co. Holdings Inc. completed the sale of its Virginia Cannabis business to an affiliate of Millstreet Credit Fund LP, generating total consideration of $130 million. The deal involves the transfer of ...
Canopy Growth Reports Q3 Fiscal 2026 Financial Results
SMITHS FALLS, ON – Canopy Growth Corp. reported its financial results for the third quarter of fiscal 2026, ended December 31, 2025, showing progress in cost control and Canadian operations despite flat overall revenue. Consolidated ...
NY Cannabis Hits First $500M Quarter
NEW YORK – New York's legal Cannabis market set a new record by closing 2025 with its first quarter exceeding $500 million in sales, positioning the state for continued strong performance into 2026. The Office ...
Organigram Holdings Partners with 4C LABS to Supply Medical Cannabis to the UK
LOS ANGELES— Organigram Holdings Inc., a recognized licensed producer of cannabis, announced today its strategic expansion into the UK market. The company has inked a supply agreement with 4C LABS, an emerging healthcare, tech, and ...
Cresco Labs Reports Q2 Results Amid Expansion Efforts
LOS ANGELES— Cresco Labs, a Chicago-based cannabis company, disclosed a 9% decline in revenues for the second quarter ended June 30, compared to the same timeframe last year. However, the company registered a modest quarter-on-quarter ...
Ohio Projects Significant Tax Revenues from Potential Cannabis Legalization
LOS ANGELES— Ohio might experience a significant influx in tax revenue from adult-use cannabis sales, estimated between $276.2 million to $403.6 million annually by the fifth year, should voters approve a prospective legalization measure this ...
atai Life Sciences Releases Promising Results from PCN-101 Phase 1 Study, Offering Potential for Home-Based Use
LOS ANGELES-- atai Life Sciences (NASDAQ: ATAI), a pioneering biotech company, has reported encouraging results from its Phase 1 investigation into the subcutaneous administration of PCN-101 (R-ketamine), facilitated through its subsidiary, Perception Neuroscience. The trial's ...
GrowGeneration Corp Reports Mixed Financial Performance Amid Challenging Cannabis Landscape
LOS ANGELES — GrowGeneration Corp., a specialty hydroponic and organic garden center chain with 62 branches across 18 states, announced its financial performance for the second quarter ending June 30, 2023. Key Takeaways: Net Sales: ...
Green Thumb Industries Reports Q2 2023 Financial Performance; Revenue Grows Sequentially
LOS ANGELES— Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), one of the prominent national cannabis consumer packaged goods companies and the proprietor of RISE Dispensaries, revealed its Q2 financial results for the period ending ...
MyMD Pharmaceuticals Receives FDA Approval to Proceed with Investigational Rheumatoid Arthritis Drug
BALTIMORE – MyMD Pharmaceuticals, Inc. announced on Monday that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) Application to study the safety and effectiveness of the oral TNF-α ...
South Dakota Takes Steps Towards Legalization of Cannabis: New Initiative Awaits Public Comment
LOS ANGELES-- South Dakota's path to legalizing cannabis took a notable step forward, as the state's Attorney General Marty Jackley (R) has officially released a draft summary of an initiative to legalize the substance. The ...
MindMed Partners with K2 HealthVentures in $50 Million Credit Facility for Brain Health Research
NEW YORK — Mind Medicine (MindMed) Inc., a clinical-stage biopharmaceutical company focused on developing innovative solutions for brain health disorders, announced today the signing of a senior secured credit facility with K2 HealthVentures, a leading ...
Columbia Care Reports Q2 Earnings: Revenue Remains Steady as Cost-Cutting Efforts Show Results
NEW YORK — Columbia Care Inc., a player in the cannabis industry, released its financial results for the second quarter ending June 30, 2023, showcasing resilience amid complex market conditions. The numbers reveal slight shifts ...
Glass House Brands Reports Record Second Quarter 2023 Financial Results
LOS ANGELES-- Glass House Brands Inc., a vertically integrated cannabis companies in the U.S., reported its financial results for Q2 2023, ending June 30. The figures reveal a record-breaking quarter for the company, with revenue ...
Michigan Poised to Become a $3 Billion Cannabis Market; July Sales Record Set
LOS ANGELES —Michigan's cannabis market is booming, on pace to reach a significant milestone this year, potentially becoming the nation's second $3-billion market. Licensed dispensaries reported record sales of $276.7 million in July 2023, with ...
Alabama Medical Cannabis Commission Revamps Licensing, Leaving Verano Holdings Out
LOS ANGELES-- The Alabama Medical Cannabis Commission has overhauled its initial round of business licensing, with some of the original winners, including Verano Holdings Inc., ending up on the losing side. The reshuffling has led ...
Mind Medicine Partners with Catalent for Innovative Psychedelic-Based Anxiety Treatment
NEW YORK — Mind Medicine Inc., known as MindMed, has secured a licensing agreement with Catalent to utilize its proprietary Zydis orally disintegrating tablet (ODT) technology for the development of a groundbreaking psychedelic-based anxiety treatment, ...
New Hampshire to Explore State-Run Cannabis Sales Through Newly Signed Bill
LOS ANGELES- Governor Chris Sununu (R) of New Hampshire, a known opponent of adult-use cannabis legalization, signed a bill on Tuesday to create a commission to study the possibility of selling cannabis through state-owned shops. ...
Cronos Group Reports Q2 2023 Financial Results, Announces Strategic Shift Amid Market Challenges
NEW YORK — Cronos Group Inc. released its financial results for the second quarter of 2023, revealing a net revenue of $19.0 million, an 11.9% decrease from the same period in 2022. The decline has ...
Cannabis Tech Platform Weedmaps Posts $2 Million Profit
LOS ANGELES–Amid a challenging period, WM Technology, known as the cannabis advertising powerhouse Weedmaps, has revealed an encouraging financial turnaround through its latest quarterly profit report. For the quarter ending on June 30, WM Technology ...
Cannabis Industry’s Branding Challenge: Beyond Packaging and Social Media
LOS ANGELES–Amid the flourishing cannabis industry, branding efforts often focus on packaging and social media, missing out on essential elements. Experts suggest that cannabis marketing needs to evolve beyond these basics to truly succeed. Cannabis ...
Germany’s Cannabis Legalization: The Debate Over Edibles and Public Health
BERLIN-- Germany is currently embarking on a significant journey toward cannabis legalization, with ministers unveiling a national cannabis reform strategy. The plan involves legalizing personal freedoms like possession and cultivation, as well as noncommercial cannabis ...
Alabama Medical Cannabis Commission to Reevaluate Licensing Process Amidst Lawsuits
LOS ANGELES— In a move that could reshape the landscape of Alabama's burgeoning cannabis industry, the Alabama Medical Cannabis Commission (AMCC) indicated in a Monday court filing its intention to nullify the licenses it awarded ...
U.S. Inflation Rebounds Slightly in July, Easing Rate Hike Concerns
LOS ANGELES-- The annual increase in the Consumer Price Index (CPI) saw a mild uptick in July 2023, marking the first rebound after 12 consecutive months of declines from over four-decade highs of 9.1% in ...
Support for Cannabis Legalization in Pennsylvania Shows Decline; New Legislation Still on the Table
LOS ANGELES-- In a surprising turn of events, support for cannabis legalization in Pennsylvania has seen a decline for the first time in a decade. The 2023 Pennsylvania Health Survey, conducted by Muhlenberg College Public ...
Montana Cannabis Ownership Law Faces Legal Challenge over Residency Requirements
LOS ANGELES-- A father-and-son investor duo are the latest to challenge state residency requirements for cannabis business ownership, a contentious issue facing multiple states. Two out-of-state investors, Tom and Jerry Reed, have filed lawsuits in ...
American Psychedelic Practitioners Association and BrainFutures Publish First-Ever Guidelines for Psychedelic-Assisted Therapy
LOS ANGELES-- The American Psychedelic Practitioners Association (APPA) in collaboration with BrainFutures has published reportedly the first set of professional practice guidelines for psychedelic-assisted therapy in the United States. These guidelines come as the FDA's ...
Curaleaf Holdings Inc. Reports 4% Year-Over-Year Revenue Growth in Q2 2023, Continues Strategic Expansion
LOS ANGELES-- Curaleaf Holdings Inc., a cannabis consumer products, reported its financial results for the second quarter ended June 30, 2023, reflecting modest growth in revenue but also an increased net loss compared to the ...
